Trial
NCT02144753
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Nutrabiotix, LLC
Collaborators
Rush University Medical Center
Condition
Constipation-predominant IBS (IBS-C)
Intervention
NTX-1
Why stopped
Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse than the psyllium group.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-02